Darwin Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $170K | Sell |
419
-7
| -2% | -$2.84K | 0.06% | 135 |
|
|
2025
Q1 | $222K | Hold |
426
| – | – | 0.07% | 126 |
|
|
2024
Q4 | $222K | Sell |
426
-10
| -2% | -$5.21K | 0.07% | 126 |
|
|
2024
Q3 | $270K | Buy |
+436
| New | +$270K | 0.07% | 123 |
|
|
2024
Q2 | – | Sell |
-430
| Closed | -$250K | – | 138 |
|
|
2024
Q1 | $250K | Buy |
430
+2
| +0.5% | +$1.16K | 0.07% | 114 |
|
|
2023
Q4 | $227K | Sell |
428
-93
| -18% | -$49.4K | 0.06% | 137 |
|
|
2023
Q3 | $264K | Sell |
521
-66
| -11% | -$33.4K | 0.07% | 123 |
|
|
2023
Q2 | $305K | Buy |
587
+158
| +37% | +$82.1K | 0.08% | 112 |
|
|
2023
Q1 | $253K | Sell |
429
-18
| -4% | -$10.6K | 0.07% | 140 |
|
|
2022
Q4 | $261K | Sell |
447
-10
| -2% | -$5.84K | 0.07% | 146 |
|
|
2022
Q3 | $236K | Buy |
+457
| New | +$236K | 0.06% | 141 |
|
|
2022
Q2 | – | Sell |
-1,340
| Closed | -$791K | – | 178 |
|
|
2022
Q1 | $791K | Sell |
1,340
-12
| -0.9% | -$7.08K | 0.13% | 99 |
|
|
2021
Q4 | $795K | Buy |
1,352
+266
| +24% | +$156K | 0.13% | 98 |
|
|
2021
Q3 | $620K | Buy |
1,086
+84
| +8% | +$48K | 0.1% | 105 |
|
|
2021
Q2 | $505K | Sell |
1,002
-5,615
| -85% | -$2.83M | 0.08% | 112 |
|
|
2021
Q1 | $3.02M | Buy |
6,617
+83
| +1% | +$37.9K | 0.53% | 51 |
|
|
2020
Q4 | $3.04M | Buy |
6,534
+5,896
| +924% | +$2.75M | 0.57% | 49 |
|
|
2020
Q3 | $281K | Buy |
638
+65
| +11% | +$28.6K | 0.06% | 131 |
|
|
2020
Q2 | $207K | Hold |
573
| – | – | 0.05% | 149 |
|
|
2020
Q1 | $162K | Sell |
573
-60
| -9% | -$17K | 0.05% | 149 |
|
|
2019
Q4 | $206K | Buy |
+633
| New | +$206K | 0.05% | 150 |
|